Skip to main content
Download PDF

Long noncoding RNA UNC5B-AS1 suppresses cell proliferation by sponging miR-24-3p in glioblastoma multiforme

BMC Medical Genomics volume 17, Article number: 83 (2024) Cite this article

Abstract

Background

Glioblastoma multiforme (GBM) is the most common primary CNS tumor, characterized by high mortality and heterogeneity. However, the related lncRNA signatures and their target microRNA (miRNA) for GBM are still mostly unknown. Therefore, it is critical that we discover lncRNA markers in GBM and their biological activities.

Materials and methods

GBM-related RNA-seq data were obtained from the Cancer Genome Atlas (TCGA) database. The “edger” R package was used for differently expressed lncRNAs (DELs) identification. Then, we forecasted prospective miRNAs that might bind to lncRNAs by Cytoscape software. Survival analysis of those miRNAs was examined by the starBase database, and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis of the miRNAs’ target genes was conducted by the Gene Set Enrichment Analysis (GSEA) database and R software. Moreover, the proliferative ability of unc-5 netrin receptor B antisense RNA 1 (UNC5B-AS1) cells was evaluated by Cell Counting Kit-8 (CCK-8) analysis. Mechanistically, the regulatory interaction between UNC5B-AS1 and miRNA in GBM biological processes was studied using CCK-8 analysis.

Results

Our results indicated that overexpression of UNC5B-AS1 has been shown to suppress GBM cell growth. Mechanistically, miR-24-3p in GBM was able to alleviate the anti-oncogenic effects of UNC5B-AS1 on cell proliferation.

Conclusion

The discovery of the novel UNC5B-AS1-miR-24-3p network suggests possible lncRNA and miRNA roles in the development of GBM, which may have significant ramifications for the analysis of clinical prognosis and the development of GBM medications.

Peer Review reports

Introduction

Glioblastoma multiforme (GBM), as the most prevalent and malignant category of central nervous system (CNS) tumours, has a very poor prognosis [1]. Every year, 3.19 cases of GBM are diagnosed per 100,000 people on average, and the median age at diagnosis is 64 [2]. To date, it is expected that the median overall survival for GBM is only 15 months after diagnosis [3]. Currently, surgical resection, adjuvant chemotherapy using temozolomide (TMZ) and radiation therapy make up the conventional treatment for GBM; however, surgery fails to cure GBM patients, and TMZ therapy always complies with the emergence of acquired resistance [4, 5]. Therefore, it is worthwhile to explore a better method for the diagnosis and therapeutic improvement of GBM. The 2021 World Health Organization Classification of Tumours of the Central Nervous System (2021 CNS WHO) advances the importance of molecular diagnostics in classifying CNS tumours [6]. However, based on our knowledge, few biomarkers have been discovered as effective treatment for GBM. Thus, it is urgent for us to digest GBM-related biomarkers and explore their biological functions in the tumorigenesis of GBM.

LncRNAs refer to RNA transcripts longer than 200 nucleotides that are not directly translated into proteins following transcription [7]. LncRNAs appear to play major roles in various cellular and biological functions of carcinogenesis and metastasis. Probably resulting from their critical roles in promoting or suppressing tumor growth, metastasis, differentiation, and different phrases of cell cycles [8, 9]. Interesting, lncRNAs are also considered competing endogenous RNAs (ceRNAs) to regulate RNA transcription by competing for the binding of microRNAs (miRNAs), which have attracted the attention of researchers [10]. Several studies have demonstrated the involvement of aberrant lncRNA levels in glioma progression via miRNA sponging, such as Linc01094, PCBP1-AS1 and MNX1-AS1 [11,12,13]. These molecular players provide novel insights into GBM and offer clues for developing anti-GBM therapies. However, the biological values and potential mechanisms of many lncRNAs in GBM have not been fully explored; finding and identifying new relevant lncRNAs and their potential mechanisms is crucial to improving the clinical outcome of GBM patients.

This study aims to identify the potential lncRNA signatures as well as their potential mechanisms for the oncogenesis of GBM. Initially, 174 GBM patients’ RNA-seq data acquired from the TCGA database were used in this work (containing 5 normal brain samples and 169 GBM samples). UNC5B-AS1 was expressed at lower levels in GBM samples and cells than in normal groups based on our bioinformatic and experimental results. We also discovered that miR-24-3p, miR-654-5p and miR-580-3p can specifically target UNC5B-AS1 and involved in the prognosis of LGG. Those miRNAs and their target genes might regulate GBM tumorigenesis by regulating pathways in cancers, mitogen activated protein kinase (MAPK) signaling pathway and cell cycle progression. Moreover, the UNC5B-AS1-miR-24-3p regulatory interaction was verified in vitro. Finally, through mechanistic exploration, we found that lncRNA UNC5B-AS1 underlies the oncogenic function by interacting with miR-24-3p. The procedure for this study is displayed in A. Figure 1 in the Additional file 1.

Materials and methods

GBM dataset preparation

In this work, GBM sample RNA-seq data were collected from the publicly available TCGA database (https://www.cancer.gov/tcga), which contains 169 GBM samples and 5 normal brain samples.

Identification of DELs in GBM

GENCODE database accesses users to annotate protein-coding and noncoding regions of human and mouse reference genomes, which draws on primary data as well as bioinformatic tools and analysis to enable the development of transcript structures and the identification of their functions [14]. We retained only the nonprotein-coding genes from the transcript sequences that were annotated in GENCODE. Then, we selected the lncRNA expression profiles across 174 GBM samples with a mean number of RPKM (reads per kilobase of exon model per million mapped reads) ≥ 0.1 [15]. Finally, lncRNAs that were expressed in at least 50% of the GBM samples were chosen for additional study. A bioconductor package called "edgeR" was used to examine differentially expressed lncRNAs between GBM and normal samples [16]. The thresholds were fixed at FDR < 0.001 and |log2FC|> 2. A volcano map and a heatmap plot were used to describe the results. All data was analyzed by R software.

Identification of potential downstream miRNAs of UNC5B-AS1

The lncRNASNP2 database offers thorough resources on single nucleotide polymorphisms (SNPs) across both human and mouse lncRNAs and provides miRNA and lncRNA interaction outcomes integrated by the Pita, TargetScan and miRanda databases [17]. We used the lncRNASNP2 web tool to discover potential downstream miRNAs of UNC5B-AS1. Cystoscope, an open-source bioinformatics software platform, is far more effective for working with large networks and provides more flexibility in terms of networking, importing, and visualizing [18, 19]. By using Cytoscape software (version 3.7.0), a coexpression network of lncRNA-miRNAs was constructed.

Three miRNAs’ targets enrichment analysis in KEGG pathways

The starBase database (https://starbase.sysu.edu.cn/index.php) is a free, accessible online tool that contains multidimensional sequencing data from 32 different kinds of cancer and enables investigation of RNA‒RNA interactions [20]. In this study, we examined the prognostic value of those miRNAs based on the miRNA's median value by using the starBase web tool. The GSEA web tool enable users to detect hallmark gene, chemical and genetic perturbations, KEGG and other gene sets analysis of mRNAs flexibility [21, 22]. We conducted enrichment analysis to explore the potential functions and mechanisms of the miRNAs’ targets based on GESA databases and visualized by the package ‘ggplot2’ built in R, we also conducted the KEGG pathway associated with GBM by Cytoscape software.

Cell culture

All cells were purchased from BeNa Culture Collection (BNCC, China). The U87MG (BNCC; 338,150; China) and HEB cell lines (BNCC; 338,123; China) were cultured in 10-cm petri dishes containing penicillin‒streptomycin solution (Gibco; 2,257,223; Thermo Fisher Scientific) and 10% foetal bovine serum (FBS; 10,099–141; Gibco; Thermo Fisher Scientific) in Dulbecco's Modified Eagle Medium (DMEM; 8,121,356; Gibco; Thermo Fisher Scientific), which was maintained at 37 °C with 5% CO2, and the cells were then passaged every 2–3 days until they reached the logarithmic growth phase [23, 24].

Quantitative real-time PCR (qRT-PCR)

We identified significant lncRNAs from those DELs for qRT‒PCR analysis. Total RNA was extracted from cells using a TRIzol kit (1 ml; QIAGEN; DP424; China) in line with the manufacturer’s guideline. Complementary DNA (cDNA) was synthesized by reverse transcription reagent containing gDNA Eraser (Cat# RR047A, TaKaRa) [25]. TB Green Premix (Cat# RR820A, TaKaRa) was used for qRT‒PCR, and the LightCycler® 96 Instrument (Roche, Switzerland) was used for analysis [26]. Based on the 2−ΔΔCt method, we normalized the results and conducted our data analysis. The internal criteria for lncRNAs and miRNAs were β-actin and U6, respectively.

Cell transfection

In this study, after 1 × 106/well U87MG cells were plated onto 6-well plates, UNC5B-AS1 overexpression Lentivirus (sh-UNC5B-AS1) and negative control (sh-NC) were transfected into the U87MG cell line at an MOI = 5 for 72 h. Furthermore, the cells were incubated for 48 h in medium containing 2 µg/mL puromycin and then cultured in fresh DMEM. The Lentivirus vector GV367 was designed by Shanghai GeneChem Company (Shanghai, China). MiR-24-3p mimics and NC mimics were acquired from RiboBio Company (Guangzhou, China), and with the use of Lipofectamine 3000 (Invitrogen, L3000150, USA), cell transfection was accomplished [27]. Twenty-four hours before transfection, U87MG cells were seeded in 24-well plates until the density reached 50%, and the transfection concentration was 50 nM based on the manufacturer's guidelines. Then, the cells in each group were harvested for subsequent experiments.

Cell proliferation assay

To assess cell proliferative capacity, the CCK-8 test was used. After transfection, U87MG cells were plated into 96‐well plates with 5 × 103 cells per well and incubated for 24 h or 48 h in an incubator at 37 °C with 5% CO2 [4]. Subsequently, the cells received 10 µL of CCK-8 solution (Beyotime, C0039, China) and were then incubated for 2 h [28]. Finally, using a microplate reader, the optical density was calculated at a wavelength of 450 nm.

Dual-luciferase assay

To identify probable binding sites between UNC5B-AS1 and miR-24-3p, the RNAhybrid (https://bibiserv.cebitec.uni-bielefeld.de/rnahybrid) web tool was utilized [29]. The artificially synthesized reporter plasmids were provided by GenePharma Company (GenePharma, Suzhou, China). A total of 5 × 104 U87MG cells per well were plated into 96-well plates. UNC5B-AS1 WNT and MUT plasmids were separately transfected with miR-24-3p mimics or negative control by utilizing Lipofectamine 3000, and a dual luciferase assay solution (Promega, E1910, USA) was used to determine the luciferase activity after 48 h: 10ul LARII regent were added to detect the fluorescence value of firefly luciferase and 10ul stop&Go solution was added to test the Renilla fluorescence. The detected relative luciferase activity was normalized to the Renilla luciferase activity.

Statistical analysis

GraphPad Prism 7.0 software was utilized to perform statistical analysis. The data are displayed as the mean ± S.D. To determine the statistical significance of a difference between two divisions, Student’s t test was used. We considered p values < 0.05 to be significant.

Results

Exploration of significant DELs and downstream miRNAs of UNC5B-AS1

A total of 622 differentially expressed lncRNAs were discovered (169 GBM tumour samples compared with 5 normal samples) with the thresholds | log 2 FC |> 2 and FDR < 0.001, including 252 upregulated lncRNAs and 370 downregulated lncRNAs (eTable 1 and eTable 2 in the Supplementary 1). The volcano map in Fig. 1A and heatmap in Fig. 1B display the distribution of the top 10 significant DELs and UNC5B-AS1.

Fig. 1
figure 1

DELs identifying process and descriptions. A DEL volcano plot. LncRNAs that are upregulated are indicated by red dots, while lncRNAs that are downregulated are indicated by green dots. B Heatmap of DELs and UNC5B-AS1. Samples are represented on the horizontal axis, and DELs are represented on the vertical axis. C UNC5B-AS1 was expressed at lower levels in GBM. D A ceRNA regulation network of UNC5B-AS1 and downstream miRNAs. The pink and yellow circles indicate UNC5B-AS1 and miRNAs, respectively. Unpaired Student’s t test was utilized in A, ****p < 0.0001

Full size image

In addition, qRT‒PCR was applied to estimate the expression of DELs. Considering that downregulated lncRNAs might serve as therapeutic targets or prognostic biomarkers in tumorigenesis, we focused on the identification of downregulated lncRNAs that orchestrate GBM progression and their phenotypic targets. Among them, lncRNA UNC5B-AS1, which was one of the prominently downregulated lncRNAs in GBM, was selected for further evaluation. As illustrated in Fig. 1C, the mRNA expression of UNC5B-AS1 in the U87MG cell line was downregulated compared to that in the HEB cell line, which is consistent with our bioinformatics analysis results above and had never been reported in GBM; therefore, we focused on UNC5B-AS1 for subsequent analysis.

We further explored the potential miRNAs that bind to UNC5B-AS1 using the lncRNASNP2 web tool. A total of 47 miRNAs were identified and visualized by Cytoscape software (Fig. 1D). The starBase web tool was utilized to explore the prognosis of the downstream miRNAs of UNC5B-AS1. A total of 523 LGG patients were divided into two groups, including a high group (N = 261 patients) and a low group (N = 262 patients), based on the median miRNA expression value. Furthermore, the overall survival of these miRNAs was analyzed by plotting KM survival curves. Our results indicated that high expression of miR-24-3p, miR-654-5p and miR-580-3p was significantly associated with LGG patients’ prognosis, respectively (Fig. 2A, B and C). P < 0.05 was considered significant.

Fig. 2
figure 2

Survival analysis of downstream miRNAs of UNC5B-AS1 in LGG. A Overall survival of miR-24-3p. B Overall survival of miR-654-5p. C Overall survival of miR-580-3p. The horizontal axis represents time (months), and the vertical axis represents percent survival. The green colour represents the high expression group (N = 261), and the brown colour represents the low expression group (N = 262). P < 0.05

Full size image

KEGG enrichment analysis of the miRNAs’ targets

KEGG enrichment analysis was carried out to determine the probable roles of miR-24-3p, miR-654-5p and miR-580-3p by the starBase database, respectively. Our findings showed that the three miRNAs' target genes were significantly correlated with the Pathways in Cancer, Regulation of Actin Cytoskeleton, Endocytosis and Glioma, suggesting potential roles for its coding proteins in various diseases (Fig. 3A-C and Tables 1, 2 and 3) and we visualized the regulatory network based on Cytoscape software (Fig. 3D). The results demonstrated that the three miRNAs might play pivotal role in administrating glioma tumorigenesis.

Fig. 3
figure 3

KEGG enrichment analysis of miRNAs’ targets. A Top 40 KEGG enrichment of the miR-24-3p target genes. B Top 40 KEGG enrichment of the miR-654-5p target genes. C Top 40 KEGG enrichment of the miR-580-3p target genes. The horizontal axis indicates GeneRatio (%), and the vertical axis indicates enrichment pathways. Count indicates gene numbers of each pathway. P < 0.05. D KEGG enrichment analysis of miRNAs’ target gene sets. The three yellow circles represent three miRNAs (miR-24-3p, miR-654-5p and miR-580-3p), respectively. The orange circles represent common enrichment pathways between miR-24-3p and miR-654-5p; The grey circles represent common enrichment pathways between miR-654-5p and miR-580-3p; The purple circles represent common enrichment pathways between miR-24-3p and miR-580-3p; The green, pink and blue circles represent independent enrichment pathways of miR-24-3p, miR-654-5p and miR-580-3p, respectively. The red circle represents glioma related pathways

Full size image
Table 1 The enrichment analysis of hsa-miR-24-3p targets in KEGG pathways
Full size table
Table 2 The enrichment analysis of hsa-miR-654-5p targets in KEGG pathways
Full size table
Table 3 The enrichment analysis of hsa-miR-580-3p targets in KEGG pathways
Full size table

To verify our bioinformatic analysis, we conducted in vitro analysis to explore the molecular biological roles of UNC5B-AS1 in GBM cells. The CCK-8 test was used to assess UNC5B-AS1's capacity for cell proliferation. Our results indicated that in contrast to LV-Vector group, the expression of UNC5B-AS1 in the LV-UNC5B-AS1 group was especially higher (Fig. 4A). The results demonstrated that cell proliferation in the LV-UNC5B-AS1 group was inhibited in contrast to that in the LV-Vector group (Fig. 4B). Overall, based on these findings, the function of UNC5B-AS1 could regulate the proliferative ability of GBM cells by sponging miR-24-3p.

Fig. 4
figure 4

UNC5B-AS1 enhanced the proliferative ability of GBM cells. A Efficiency of UNC5B-AS1 overexpression in U87MG cells. B UNC5B-AS1 inhibited cell proliferation. Time is represented on the horizontal axis, and cell viability is represented on the vertical axis. The black and grey pillars indicate LV-Vector and LV-UNC5B-AS1, respectively. Unpaired Student’s t test was utilized in a, and two-way ANOVA with Sidak’s multiple comparisons test was utilized in b. C Overexpression of miR-24-3p attenuated the effects of UNC5B-AS1 on GBM cell proliferation. Multiple t test was utilized in B, Two-way ANOVA with Tukey’s multiple comparisons test was utilized in C, **p < 0.01, ***p < 0.001 and ****p < 0.0001

Full size image

UNC5B-AS1 regulate cell proliferation through the ceRNA sponging of miR-24-3p

To detect the potential binding sites of UNC5B-AS1, qRT‒PCR analysis was utilized, and the results indicated that increased expression of UNC5B-AS1 repressed the expression of miR-24-3p (Fig. 5A). Figure 5B shows that miR-24-3p expression was significantly higher in U87MG cells than in HEB cells. Moreover, miR-24-3p overexpression inhibited the expression of UNC5B-AS1 in U87MG cells (Fig. 5C). Figure 5D demonstrates the miR-24-3p mimic transfection efficiency.

Fig. 5
figure 5

MiR-24-3p is sponged by UNC5B-AS1 in GBM. A UNC5B-AS1 overexpression inhibited miR-24-3p expression in the U87MG cell line. B The expression of miR-24-3p was significantly high in GBM. C Enhanced expression of miR-24-3p suppressed UNC5B-AS1 expression in the U87MG cell line. D Efficiency of the miR-24-3p mimics. Unpaired Student’s t test was utilized in A-D, *p < 0.05, **p < 0.01 and ****p < 0.0001. E Possible binding locations between UNC5B-AS1 and miR-24-3p. F The relative luciferase activity after transfection of both the miR-24-3p mimic and the 3’UTR of UNC5B-AS1 mRNA into U87MG cells

Full size image

Additionally, the probable binding regions between UNC5B-AS1 and miR-24-3p were estimated using RNAhybrid (Fig. 5E). The dual luciferase reporter assay revealed that, in comparison to wild-type UNC5B-AS1 mimics of the NC group, wild-type UNC5B-AS1 transfected with miR-24-3p mimics had suppressed luciferase activity, whereas the luciferase activity of the mutant-type UNC5B-AS1 mimic NC group and mutant-type UNC5B-AS1 miR-24-3p mimics were similar (Fig. 5F). These findings predicted that UNC5B-AS1 may target miR-24-3p, thereby affect the biological process of GBM.

We further evaluated the association of UNC5B-AS1 and miR-24-3p in U87MG cells by CCK-8 experiments. The findings revealed that UNC5B-AS1 overexpression suppressed GBM cell proliferation, whereas cotransfection of miR-24-3p mimics and LV-UNC5B-AS1 effectively diminished the inhibitory effects of UNC5B-AS1 overexpression on U87MG cells (Fig. 4C).

Conclusion

Long noncoding RNAs (lncRNAs), a recent innovation in molecular biology, are crucial for controlling gene expression at the stages of the epigenome, transcription and posttranscription [30]. LncRNAs, which appear to act as miRNA sponges, can negatively attenuate protein-coding gene expression and then regulate cell differentiation and progression in various diseases, including GBM and other cancers. Numerous lncRNAs and their sponged targets have been identified as both diagnostic and therapeutic targets in the development of GBM tumours, such as LINC02015, H19, KIAA0495, AC068888.1 and MALAT1 [31,32,33,34]. In spite of the ceRNAs theory has made considerable progress in the development of diagnostic markers, little is known about the role of lncRNAs and its combined targets in GBM development. Moreover, the lack of sensitive and specific GBM biomarkers has resulted in overdiagnosis and overtreatment [35]. Hence, for the effective diagnosis and treatment of GBM, there is an urgent need to discover GBM-related lncRNAs and uncover their potential mechanisms.

UNC5B-AS1 is a novel carcinogenic lncRNA that has been found in thyroid papillary carcinoma, ovarian cancer, colon cancer and prostate cancer. For example, UNC5B-AS1 was considered to exert a crucial role in cell growth and metastasis of papillary thyroid cancer (PTC) and may be a therapeutic target for PTC [36]. In addition, UNC5B-AS1 accelerates the proliferation, migration, and epithelial-mesenchymal transition (EMT) of hepatocellular carcinoma (HCC) cells via sponging miR-4306 [37]. However, its exact biological roles and direct targets in the progression of GBM are still unknown. In this study, we aimed to discover the roles of UNC5B-AS1 in glioma and investigate its potential mechanisms in the development of GBM. Additionally, many therapeutic targets of UNC5B-AS1 are needed to be explored for GBM treatment.

MiRNAs act as post-transcriptional regulators of gene expression, with 22 ~ 25 nucleotides in length. MiRNAs can be significantly overexpressed in many cancer cells and exert biological roles via interacting with target mRNAs. For example, miR-22-3p can target Wnt-signaling pathway-associated mRNAs and promote the carcinogenesis of colon cancer cells [38]. In glioma, miR-24-3p can specially target the 3’ UTR of MAX interactor 1 (Maxi 1) to promote the cell proliferation [39]. Based on the background above, in this study, we performed bioinformatic analysis and survival analysis to screen potential miRNAs of UNC5B-AS1 and explore its biological functions in vitro. We assumed that miR-24-3p might act as a target of UNC5B-AS1 and be involved in regulating tumor development, which will provide a deeper understanding of GBM development.

To validate our assumptions, we aimed to determine abnormally expressed lncRNAs and miRNAs, as well as their biological regulatory roles in GBM cells. In this study, we firstly discovered the roles of UNC5B-AS1 was downregulated in GBM cells, which is consistent with the bioinformatic analysis. In addition, we found that overexpressed UNC5B-AS1 inhibited cell proliferation, indicates that UNC5B-AS1 might act as tumor suppressor in GBM. We also found that miR-24-3p can sponge UNC5B-AS1 to reverses the effect of cell proliferation, demonstrates the potential biological mechanisms of UNC5B-AS1 in GBM. Moreover, miR-24-3p was significantly associated with LGG patients’ prognosis, indicates that UNC5B-AS1 may interact with miR-24-3p to influence patents’ survival. However, more experiments are needed to further test these hypotheses. Based on our results, a novel UNC5B-AS1/miR-24-3p regulation axis was constructed, which may act a key pathway in the GBM development and become a new therapeutic application of GBM in the foreseeable future.

The current work also has a few shortcomings. First, in the TCGA dataset, we solely examined and verified the biological roles of lncRNA biomarkers, and no other database of lncRNA expression data associated with GBM was used for further validation. Second, the interaction between UNC5B-AS1 and miR-24-3p were only explored by the qRT-PCR analysis and luciferase assay. More experiments, including RNA pull down and immunoprecipitation (RIP). However, we will process more intensive research on anther experiments in the future. Finally, this study used a database mining design without validation in fresh samples due to our limited conditions, such as patients’ tissues and animal experimental studies. We hope to perfect our work in the future.

In conclusion, our study suggested the potential functions of the UNC5B-AS1-miR-24-3p regulatory link, which may serve as cutting-edge potential biomarkers for GBM diagnosis and prognosis.

Availability of data and materials

These data utilized to back up the study’s findings is supplied in the article.

References

  1. Walbert T, Mikkelsen T. Recurrent high-grade glioma: a diagnostic and therapeutic challenge. Expert Rev Neurother. 2011;11(4):509–18.

    Article  PubMed  Google Scholar 

  2. Thakkar JP, et al. Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev. 2014;23(10):1985–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Marenco-Hillembrand L, et al. Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis. J Neurooncol. 2020;147(2):297–307.

    Article  PubMed  Google Scholar 

  4. Matias D, et al. Dual treatment with shikonin and temozolomide reduces glioblastoma tumor growth, migration and glial-to-mesenchymal transition. Cell Oncol (Dordr). 2017;40(3):247–61.

    Article  CAS  PubMed  Google Scholar 

  5. Zanders ED, Svensson F, Bailey DS. Therapy for glioblastoma: is it working? Drug Discov Today. 2019;24(5):1193–201.

    Article  PubMed  Google Scholar 

  6. Louis DN, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Matsui M, Corey DR. Non-coding RNAs as drug targets. Nat Rev Drug Discov. 2017;16(3):167–79.

    Article  CAS  PubMed  Google Scholar 

  8. Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77(15):3965–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. El Fattah Abd YK, et al. Interactome battling of lncRNA CCDC144NL-AS1: its role in the emergence and ferocity of cancer and beyond. Int J Biol Macromol. 2022;222(Pt B):1676–87.

    Article  Google Scholar 

  10. Liu Z, et al. Long noncoding RNA PICSAR/miR-588/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K/AKT/mTOR signaling pathway. Cancer Sci. 2020;111(11):4118–28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Li XX, Yu Q. Linc01094 accelerates the growth and metastatic-related traits of glioblastoma by sponging miR-126-5p. Onco Targets Ther. 2020;13:9917–28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Li Z. LncRNA PCBP1-AS1 induces osteoporosis by sponging miR-126-5p/PAK2 axis. Bone Joint Res. 2023;12(6):375–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Gao Y, et al. lncRNA MNX1-AS1 promotes glioblastoma progression through inhibition of miR-4443. Oncol Res. 2019;27(3):341–7.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Frankish A, et al. GENCODE 2021. Nucleic Acids Res. 2021;49(D1):D916-d923.

    Article  CAS  PubMed  Google Scholar 

  15. Shi D, et al. A five-long non-coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma. Oncotarget. 2017;8(35):58699–708.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2009;26(1):139–40.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Miao Y-R, et al. lncRNASNP2: an updated database of functional SNPs and mutations in human and mouse lncRNAs. Nucleic Acids Res. 2017;46(D1):D276–80.

    Article  PubMed Central  Google Scholar 

  18. Shannon P, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–504.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Doncheva NT, et al. Cytoscape StringApp: network analysis and visualization of proteomics data. J Proteome Res. 2019;18(2):623–32.

    Article  CAS  PubMed  Google Scholar 

  20. Li J-H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2013;42(D1):D92–7.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Mootha VK, et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34(3):267–73.

    Article  CAS  PubMed  Google Scholar 

  23. Chen X, et al. Long noncoding RNA LINC00346 promotes glioma cell migration, invasion and proliferation by up-regulating ROCK1. J Cell Mol Med. 2020;24(22):13010–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Tadayoni Nia A, et al. WDR81 gene silencing can reduce exosome levels in human U87-MG glioblastoma cells. J Mol Neurosci. 2021;71(8):1696–702.

    Article  CAS  PubMed  Google Scholar 

  25. Yu W, et al. Identification of immune-related lncRNA prognostic signature and molecular subtypes for glioblastoma. Front Immunol. 2021;12:706936.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Ma Q, Wang X, Li J. LncRNA RP1–86C11.7 exacerbates the glioma progression and oncogenicity by hsa-miR-144–3p/TFRC signaling. Transl Oncol. 2021;14(12):101215.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Alexander BM, Cloughesy TF. Adult glioblastoma. J Clin Oncol. 2017;35(21):2402–9.

    Article  CAS  PubMed  Google Scholar 

  28. Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10(3):155–9.

    Article  CAS  PubMed  Google Scholar 

  29. Rehmsmeier M, et al. Fast and effective prediction of microRNA/target duplexes. RNA. 2004;10(10):1507–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Zhu J, et al. Function of lncRNAs and approaches to lncRNA-protein interactions. Sci China Life Sci. 2013;56(10):876–85.

    Article  CAS  PubMed  Google Scholar 

  31. Baspinar Y, et al. Long non-coding RNA MALAT1 as a key target in pathogenesis of glioblastoma. Janus faces or Achilles’ heal? Gene. 2020;739:144518.

    Article  CAS  PubMed  Google Scholar 

  32. Gao WZ, et al. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients. J Transl Med. 2018;16(1):368.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Xiao Y, et al. Expression and prognostic value of long non-coding RNA H19 in glioma via integrated bioinformatics analyses. Aging (Albany NY). 2020;12(4):3407–30.

    Article  CAS  PubMed  Google Scholar 

  34. Zhang XQ, et al. A long non-coding RNA signature in glioblastoma multiforme predicts survival. Neurobiol Dis. 2013;58:123–31.

    Article  CAS  PubMed  Google Scholar 

  35. Misawa A, Takayama K-I, Inoue S. Long non-coding RNAs and prostate cancer. Cancer Sci. 2017;108(11):2107–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Wang Y, et al. The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines. Hum Cell. 2019;32(3):334–42.

    Article  CAS  PubMed  Google Scholar 

  37. Huang X, et al. UNC5B-AS1 promotes the proliferation, migration and EMT of hepatocellular carcinoma cells via regulating miR-4306/KDM2A axis. Cell Cycle. 2021;20(20):2114–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Gao Z, et al. miR-24-3p promotes colon cancer progression by targeting ING1. Signal Transduct Target Ther. 2020;5(1):171.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Xu W, et al. miR-24-3p and miR-27a-3p promote cell proliferation in glioma cells via cooperative regulation of MXI1. Int J Oncol. 2013;42(2):757–66.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

National Natural Science Foundation of China (22067015), The Shenzhen Science and Technology Innovation Project [grant numbers: JCYJ20190822090801701 and JCYJ20230807095124046] and Peking University Shenzhen Hospital—Ye Chenghai Charity Foundation provided funding for this project.

Author information

Authors and Affiliations

  1. Department of Neurology, Peking University Shenzhen Hospital, Shenzhen, 518036, China

    Ying Song, Huili Jiao & Li Yi

  2. Department of Neurosurgery, Peking University Shenzhen Hospital, Shenzhen, 518036, China

    Baodong Chen

Authors
  1. Ying Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Baodong Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Huili Jiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Li Yi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Li Yi and Ying Song conceptualized and designed the study. Ying Song, Baodong Chen, Huili Jiao conducted the analysis and wrote the article. The final draft was reviewed and approved by all authors.

Corresponding author

Correspondence to Li Yi.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Song, Y., Chen, B., Jiao, H. et al. Long noncoding RNA UNC5B-AS1 suppresses cell proliferation by sponging miR-24-3p in glioblastoma multiforme. BMC Med Genomics 17, 83 (2024). https://doi.org/10.1186/s12920-024-01851-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12920-024-01851-5

Keywords

BMC Medical Genomics

ISSN: 1755-8794

Contact us